FGF signaling is required for determination of otic neuroblasts in the chick embryo  by Alsina, Berta et al.
www.elsevier.com/locate/ydbio
Developmental Biology 267 (2004) 119–134FGF signaling is required for determination of otic
neuroblasts in the chick embryo
Berta Alsina,a,* Gina Abello´,a Encarna Ulloa,a Domingos Henrique,b
Cristina Pujades,a and Fernando Giraldeza
aBiologia del Desenvolupament, Departament de Cie´ncies Experimentals i de la Salut (DCEXS), Universitat Pompeu Fabra, 08003, Barcelona, Spain
b Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisboa, PortugalReceived for publication 14 May 2003, revised 1 October 2003, accepted 10 November 2003Abstract
The interplay between intrinsic and extrinsic factors is essential for the transit into different cell states during development. We have
analyzed the expression and function of FGF10 and FGF-signaling during the early stages of the development of otic neurons. FGF10 is
expressed in a highly restricted domain overlapping the presumptive neurogenic region of the chick otic placode. A detailed study of the
expression pattern of FGF10, proneural, and neurogenic genes revealed the following temporal sequence for the onset of gene expression:
FGF10>Ngn1/Delta1/Hes5>NeuroD/NeuroM. FGF10 and FGF receptor inhibition cause opposed effects on cell determination and cell
proliferation. Ectopic expression of FGF10 in vivo promotes an increase in NeuroD and NeuroM expression. BrdU incorporation experiments
showed that the increase in NeuroD-expressing cells is not due to an increase in cell proliferation. Inhibition of FGF receptor signaling in otic
explants causes a severe reduction in Neurogenin1, NeuroD, Delta1, and Hes5 expression with no change in non-neural genes like Lmx1.
However, it does not interfere with NeuroD expression within the CVG or with neuroblast delamination. The loss of proneural gene
expression caused by FGF inhibition is not caused by decreased cell proliferation or by increased cell death. We suggest that FGF signaling in
the otic epithelium is required for neuronal precursors to withdraw from cell division and irreversibly commit to neuronal fate.
D 2003 Elsevier Inc. All rights reserved.Keywords: Otic neuroblast; Chick embryo; Neuroblast
Introduction neurons, with a precise and exquisite topology (SwansonThe vertebrate inner ear is a complex sensory organ
responsible for the sensations of sound and balance, as
well as a variety of reflexes. The inner ear derives from the
otic placode that is formed early in development in the
ectoderm adjacent to the hindbrain and develops later into
the otic vesicle. The otic vesicle undergoes complex
morphogenesis resulting in a highly organized apparatus
named the ear labyrinth that holds the ear sensory organs.
What is striking in ear development is that the apparently
homogeneous otic placode—formed by no more than few
thousand cells—contains the cues and information to
generate different cell types, including the innervating0012-1606/$ - see front matter D 2003 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2003.11.012
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Otic neurons connect sensory mechano-receptors of the
ear, the hair-cells, with their targets in the central nervous
system. The generation of otic neurons is a sequential
process, which includes first, the specification of otic
precursors in the otic epithelium, secondly, the delamination
of epithelial neuroblasts to form the cochleovestibular
ganglion (CVG), thirdly, the proliferative expansion of
ganglionar neuroblasts, and finally, the differentiation of
neurons that innervate back the vestibular and cochlear
(auditory) sensory organs (reviewed in Alsina et al., in
press). The first visible output of otic neurogenesis is the
delamination of otic neuroblasts from the otic vesicle and
the formation of the CVG, but cell fate specification starts
much earlier in otic development, at the otic placode stage
(Adam et al., 1998).
Vertebrate proneural genes are basic helix–loop–helix
(bHLH) proteins with homology to Drosophila proneural
genes. Neurogenins have conserved the neuronal determina-
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NeuroD is required for neuronal differentiation and survival
(Bertrand et al., 2002; Cau et al., 2002). Early expressed
proneural genes are involved in the selection of progenitor
cells that become competent to acquire defined cell fates and
commit to differentiation (Cau et al., 2002). Accordingly, the
inactivation of Neurogenin1 or NeuroD causes a reduction in
the output of otic neurons (Kim et al., 2001; Liu et al., 2000;
Ma et al., 1998, 2000).
The activity of the proneural genes is influenced by cell
extrinsic signals. Secreted factors mediate crucial steps in
development like cell growth and survival, bias between
self-renewal and differentiation, or choices between differ-
ent cell fates (Edlund and Jessell, 1999; Vaccarino et al.,
1999). Fibroblast growth factors (FGFs) play multiple roles
in cell communication during development, and are attrac-
tive candidates for regulation of critical steps in neuro-
genesis (Menard et al., 2002; Vaccarino et al., 1999).
Interestingly, FGF signaling has been shown to be required
for neural induction in the chick embryo (Wilson and
Edlund, 2001), induction of posterior neuronal precursors
in the neural tube (Henrique et al., 1997), early differenti-
ation of retinal ganglion cells (McCabe et al., 1999), and for
crucial steps in olfactory development and regeneration
(Schwob, 2002).
Our study was prompted by the observation that FGF10
is expressed in the presumptive neural-sensory epithelium
of the otic vesicle (Pirvola et al., 2000, in mouse, and our
results in the chick—see below). The present work was
aimed at studying the function of FGF10 and FGF-
signaling in early otic neurogenesis. We carried out a
detailed analysis of the expression of FGF10 and several
proneural and neurogenic genes on the chick otic vesicle,
to then study the effects of gain- and loss-of-function of
FGF10 on the generation of otic neurons. The results show
that FGF10 expression defines an early regional domain
that anticipates proneural and neurogenic gene expression
in the otic placode. The sequence in the onset of gene
expression is FGF10>Ngn1/Delta1/Hes5>NeuroD/M.
Overexpression of FGF10, FGF10 delivery with microbe-
ads in ovo, or the addition of FGF10 to otic explants
increases the number of cells expressing NeuroD and
NeuroM, but not Delta1. On the contrary, FGF-receptor
blockade produces a reduction of NeuroD, Delta1, Ngn1,
and Hes5 expressing cells. The combined analysis of cell
proliferation, cell death, and gene expression suggests that
FGF signaling is required for the transit toward the state of
neuronal determination.Materials and Methods
Embryos
Fertilized hens’ eggs (Granja Gibert, Tarragona, Spain)
were incubated at 38jC for designated times and embryoswere staged according to Hamburger and Hamilton (1951).
Embryos were dissected from the yolk and fixed by immer-
sion in 4% paraformaldehyde in phosphate-buffered saline
(PBS; pH 7.4) at 4jC for 24 h.
Organotypic explants
Otic placode explants were done as reported by Giraldez
(1998). Briefly, transverse sections of chick embryos were
aseptically isolated and microdissected. Embryos were sec-
tioned behind the rhombo-mesencephalic limit and before
the second-third somite, and the heart was removed. The
explant was formed by the neuroectoderm, the adjacent
ectoderm, and the pharyngeal endoderm. Incubation was
carried out in Dulbecco’s modified Eagle medium DMEM
(Gibco) at 37.5jC in atmosphere of 5% CO2. For organo-
typic cultures of otic vesicles and CVG, otic vesicles were
dissected from embryos corresponding to stages 17–18,
transferred into 4-well culture plates (NUNC, Roskilde,
Denmark), and incubated in DMEM at 37jC in a water-
saturated atmosphere containing 5% CO2 as described (Leo´n
et al., 1995). Additions were 1% fetal calf serum (Bio
Whittaker Europe), 100–200 ng/ml human recombinant
FGF10 (R&D), and 5–50 AM SU5402 (Calbiochem).
Whole-mount in situ hybridization and immunochemistry
Whole-mount in situ hybridization was carried out
according to Wilkinson and Nieto (1993). Details of
FGF10 probe are given in (Ohuchi et al., 1997), Delta1
(Henrique et al., 1995), Neurogenin1 (Begbie et al., 2002),
NeuroD, NeuroM and Lunatic Fringe (Laufer et al., 1997),
and Lmx1 (Giraldez, 1998). The chick HES5 probe will be
described elsewhere (Henrique et al., unpublished). Whole-
mount immunohistochemistry after in situ hybridization was
used to detect several antigens. Embryos were blocked at
room temperature with 5% Blocking Reagent (Roche in
Maleic acid buffer), 5% Goat Serum in PBT(0.1% Tween)
for 90 min, incubated overnight with the primary antibody
(2% blocking reagent, 5% goat serum, RT), washed with the
same solution 10, and incubated with secondary antibodies
overnight. Embryos were rinsed several times in PBT before
mounting in Mowiol. Anti-HNK1 monoclonal antibody
(347390, Becton Dickinson; 1:50) and anti-Tuj1 monoclonal
antibody (Covance; 1:200) have been used as primary anti-
bodies, while goat anti-rabbit Alexa 549 and goat anti-mouse
Alexa 488 (Molecular Probes; 1:200) have been used as
secondary antibodies.
Density of NeuroD-expressing cells was measured as
follows. Briefly, number of cells expressing NeuroD in
control, FGF10 and SU5402 treated otic vesicles were
counted by eye (n = 2). ProNS area (area of detected
NeuroD expression) was delineated and measured by the
NIH program Scion Image. Density of NeuroD-expressing
cells is expressed as number of NeuroD-expressing cells per
unit of proNS surface area.
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Explants and otic vesicles were incubated with 10 Ag/
Al 5-Bromo-2V-deoxyuridine (Aldrich) added to the culture
medium 2 h before fixation. After in situ hybridization
procedure, explants and otic vesicles were incubated in
2N HCl for 30 min, three times washed in Sodium Borate
pH 8.9, and processed for immunohistochemistry as
described above. BrdU mAb BMC9318 antibody (Roche)
was used in whole-mount at 1:200 dilution. Cells with
BrdU labeling were also counted in the proNS domain
and density expressed as the number of BrdU-labeled
cells per arbitrary unit of surface area (square of 100 
100 pixels).
Distribution of apoptotic cells in the otic vesicle was
determined by Tdt-mediated dUTP nick end labeling
(TUNEL) of the fragmented DNA. Briefly, cultured otic
vesicles were fixed for 2 h with 4% (w/v) paraformaldehyde
in PBS and dehydrated by a series of graded methanol steps.
After rehydration, otic vesicles were incubated with 10 Ag/
ml proteinase K (Sigma) for 2 min at room temperature and
post-fixed with 4% paraformaldehyde and 0.1% glutaralde-
hyde in PBS. The otic vesicles were then incubated with the
terminal deoxynucleotidyl-transferase labeling mix for 30
min at 37jC (Roche Molecular Biochemicals) and subse-
quently added the reaction enzyme terminal deoxynucleo-
tidyl-transferase (Roche Molecular Biochemicals) and
incubated for 2 h at 37jC. The reaction was stopped by
incubation with 2 mM EDTA in PBS for 1 h at 65jC.
Fluorescein-labeled deoxynucleotides incorporated in apo-
ptotic cells were visualized in a DMR Leica fluorescence
microscope. Images were converted to grayscale and
inverted in Adobe Photoshop to enhance the apoptotic cells.
Only apoptotic cells of the epithelium next to the CVG
labeled by TUNEL were counted in control, FGF10- and
SU5402-treated vesicles. Density of apoptotic cells was also
expressed as number of cells per arbitrary unit of surface
area (square of 100  100 pixels). Student’s t test was used
for statistics when necessary.
Cryostat and vibratome sectioning
For cryostat sectioning, embryos were fixed in 4%
paraformaldehyde, dehydrated in 15% sucrose, and embed-
ded in 30% gelatin/15% sucrose. Blocks were frozen in
isopentane to improve tissue preservation and then sec-
tioned at 10 Am thickness onto Superfrost Plus Slides
(Fisher, Pittsburg, PA) and stored at 20jC.
For immunohistochemistry on frozen sections, the fol-
lowing protocol was used. Sections were blocked in 10%
goat serum, 3% BSA for 1 h, and then incubated with
primary antibodies in blocking solution at 4jC overnight.
Then, 10 washes with PBT (15 min each) were applied
before incubating with secondary antibodies for 2 h at
room temperature. Sections were then extensively washed
in PBT before mount in Mowiol. Anti-Islet 1/2 (From the
B. Alsina et al. / DevelopmeDevelopmental Studies Hybridoma Bank; 1:200), anti-
Tuj1 (Covance; 1:400) and anti-pH3 (Upstate Biotechnol-
ogy; 1:400) were used as primary antibodies. Same
secondary antibodies were used as described before but
diluted 1:400.
Bead implantation
Bead implantation was carried out on stages 10–12
embryos. Heparin-coated acrylic beads (Sigma) were
washed in PBS and soaked in human recombinant FGF10
(R&D, 1 mg/ml) for 2 h at 4jC, plus another 30 min at room
temperature. Beads were implanted through a window
opened in the egg and using Fast Green (3 mg/ml, Sigma)
for better contrast of the embryo. A slit was made through
the vitelline membrane and through the ectoderm immedi-
ately anterior or posterior to the otic placode. Eggs were
sealed and incubated during 20–24 h, when they were
collected and fixed overnight in 4% paraformaldehyde/
PBS at 4jC. Results were obtained from implantations that
resulted in beads located within one bead diameter from the
otic vesicle.
In ovo electroporation
In ovo electroporation was used to obtain ectopic ex-
pression of FGF10 in the otic placode of stage 10–13. The
full coding sequence of FGF10 (gift from Hideyo Ohuchi,
University of Tokushima, Japan) was subcloned in to the
bicistronic vector pCAGGS-IRES-GFP (Bekman and Hen-
rique, unpublished). A small hole was made into the
vitelline membrane to expose the otic placode. Platinum
electrodes (0.5 mm diameter) were placed 5 mm apart,
sandwiching the embryo. Vector (3–5 Ag/Al) mixed with
Fast Green (0.4 Ag/Al) was electroporated by injection onto
the otic placode/cup by a gentle air pressure through a fine
micropipette. Square pulses (ten 25 V pulses, 25-ms pulse
length, 10 Hz) were generated by an electroporator Square
CUY-21 (BEX Co., LTD, Tokiwasaiensu, Japan). Cold
medium (M-199) was added before and immediately after
each electroporation. Eggs were sealed and incubated for 24
h. Embryos were then examined under the fluorescent
microscope for green fluorescence signal. Embryos with
good GFP staining in the otic vesicle were collected and
fixed overnight in 4% paraformaldehyde/PBS at 4jC for
further analysis.Results
Expression of FGF10 during development of the otic vesicle
In the chick, the otic placode is visible at stage 10 as a
thickening of the ectoderm adjacent to rhombomeres 5 and
6. By stage 12, the otic placode invaginates to form the otic
cup and then closes up and pinches off from the ectoderm,
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reference to the otic placode (stage 10), early otic cup
(stages 12–14), and late otic cup (stages 15–16). The
earliest expression of FGF10 was observed in the otic
placode, at stage 11–12, restricted to the most anterior and
medial region of the otic placode (Fig. 1A). Fig. 1B shows
a low magnification photomicrograph that illustrates the
highly regionalized pattern of expression of FGF10 in
chick embryos between stages 12 and 16. Expression ofFig. 1. Early expression profile of FGF10 during otic development. (A) FGF10
domain. (B) Embryos of stages 12, 14 and 16 in which FGF10 was detected in the
primordium of the olfactory placode (olp). C and D show dorsal and lateral views
and G illustrate the expansion of this domain to more posterior positions in stage
invaginated and closed up from stage 15 to stage 16, FGF10 was excluded from t
view of a stage-16 embryo showing FGF10 expression profile with a triangular sh
show the expression of FGF10 in a stage 19 embryo. The otic vesicle was close
equatorial. In the right panels, three-dimension schematic drawings show the ideal
the other photographs.FGF10 was also detected in the endoderm of the fourth
visceral pouch (not shown) and in the primordium of the
olfactory placode (Olp in Fig. 1B). At the otic cup stage,
FGF10 expression extended to the anterior-medial half of
the otic cup, keeping always within the ridge of the otic
cup (Figs. 1C and D). Dorsal views (Figs. 1C and E)
illustrate the division of the otic cup into two territories by
an axis running from anterior-lateral to posterior-medial, at
about 45j with respect to the anterior-posterior axis of theexpression in a stage 11 embryo was found restricted to an antero-medial
otic placode/vesicle (op), the endoderm of the fourth visceral pouch and the
of stage 13 embryos with FGF10 expression in the antero-medial domain. E
s 15 and 16 embryos. (F and H) lateral views showing how as the otic cup
he dorsal region and detected in an antero-ventral position. H’ is an oblique
ape, and its narrow angle pointing to posterior and medial positions. I and J
d and the FGF10 domain restricted to a narrow band running medial and
ized expression profile of FGF10. In B, scale bar is 1 mm, and 250 Am for
Fig. 2. Early AP regionalization of the otic cup. (A) Early expression of
FGF10 (a) and HNK1 (b) were detected in complementary domains in a
stage-13 embryo, subdividing the cup into an anterior and a posterior
region. HNK1 is a carbohydrate moiety bound to many cell adhesion and
recognition molecules. Lmx1, a gene from the LIM-domain family, was also
expressed complementary to the posterior domain in a stage-13 embryo and
also expressed in the otic ridge (c), while Lunatic Fringe was detected in
the anterior domain but excluded from the ridge (d). Note the bisection of
the cup in an anterior and posterior domain by an axis running 45j from the
AP axis of the embryo. (B) Sagittal cryostat section with double detection
of Delta1 (a) and HNK1 (b) that were also expressed in complementary
domains in a stage 15 embryo. In (c), immunostaining of earliest
delaminating neuroblasts with Islet1/2 epitope (red) in a stage-15 embryo
shows delamination at the posterior border of FGF10-expressing cells
(blue). Neuroblasts delaminating at the boundary between the anterior
FGF10 domain and the posterior FG10-negative domain are represented in
a three-dimensional drawing (d). A are dorsal views, anterior to the top and
lateral to the right. B are lateral views with dorsal to the top and anterior to
the right.
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rior domain was also evident in the otic cup and early otic
vesicle from a lateral view (Figs. 1D and F). At the stage of
otic vesicle (Figs 1G and H), FGF10 transcripts were
detected anterior and medial, excluding the dorsal-most
aspect of the otic vesicle. FGF10 covered a spherical
triangle that was better seen in oblique views (see Fig.
1H’ and the diagram in Fig. 1). At stages 18–19, the
FGF10 domain transformed into an anterior-medial band
that run through the equator of the otic vesicle (Figs. 1I and
J). No FGF10-expressing cells were observed in the
cochleovestibular sensory neurons, in contrast to what
has been described in the mouse (Pirvola et al., 2000). A
three-dimensional schematic drawing illustrating the dy-
namics of FGF10 expression and the transition from the
otic placode to the otic vesicle is shown in Fig. 1 (right
panel diagrams). In summary, FGF10 expression pattern
was very dynamic, first subdividing the placode/cup into
an anterior and posterior domain and later on becoming
regionalized into a ventral band. Probably, this reflects the
displacement of a coherent domain during the morphoge-
netic events that drive the transformation of the otic
placode into the otic vesicle, rather than switching on
and off the expression of FGF10 (see Brigande et al.,
2000 and discussion).
FGF10 and the early anterior–posterior regionalization of
the otic placode
As mentioned above, the early expression of FGF10 is
one of the earliest signs of regionalization of the otic
placode. It was interesting to test whether other genes were
also restricted along the same domains that FGF10. Simul-
taneous staining of FGF10 and HNK1 expression revealed
two complementary domains in the early otic cup (Figs. 2Aa
and b). HNK1 is a sugar residue carried by several recog-
nition molecules (see Discussion). At stage 13, Lmx1,
encoding a LIM-domain protein, was expressed in the otic
ridge, and in the posterior region of the otic placode and otic
cup (Fig. 2Ac). Later on, at the otic vesicle stages, Lmx1
was absent from the neural-sensory domain in a manner
complementary to FGF10 (Giraldez, 1998, and results not
shown). Lunatic Fringe (Lfng) was also expressed in the
anterior territory and excluded from the otic ridge (Fig.
2Ad). Genes detected in the anterior domain (FGF10, Lfng,
and other genes described below) did not extend beyond the
boundary FGF10/HNK1. This is illustrated by the double
detection of HNK1 domain (green anti-HNK1 antibody
staining) and Delta1 (blue, in situ hybridization) in a
stage-14 otic cup. Figs. 2Ba and b show that the HNK1-
expressing domain was complementary to that of Delta1.
We further examined the relationship between the AP
expression boundary and otic neuron generation. Fig. 2Bc
illustrates delaminating neuroblasts that were identified with
the Islet1/2 antibody (red), along with FGF10 expression
detected by in situ hybridization (blue) on the same prep-aration. Neuroblasts delaminated only from a narrow stripe
situated along the posterior boundary of the FGF10 domain,
as confirmed by serial parasagittal sections running from
lateral to medial (results not shown). The schematic drawing
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otic neuroblasts. This observation suggests that neuroblasts
delaminate only from a subdomain of the neurogenic
domain and not from the whole neurogenic domain as
frequently assumed, and suggests a potential role of the
AP boundary in the process.
FGF10 is expressed in the proneural-sensory territory
(proNS) of the otic placode: early expression of proneural
genes
The expression pattern of FGF10 recalls that of some
proneural and neurogenic genes in the otic vesicle (Adam et
al., 1998; Begbie et al., 2002; Cole et al., 2000), suggesting a
possible relation between FGF10 and otic neurogenesis. To
further study this possibility, we carried out a systematic
study of the expression profiles of proneural genes and
compare them with FGF10 expression pattern. Fig. 3A
shows a dorsal view of stages 14–15 otic cups, where the
expression of FGF10 is compared to that of Neurogenin1
(Ngn1), Delta1, Hes5, NeuroD, and NeuroM. Ngn1 is a
neuronal determination gene in cranial sensory ganglia as
observed by loss of function studies, in which the CVG is
also missing (Ma et al., 1998). Ngn1 expression was detected
at stage 11 chick embryos, when individual Delta1-positive
cells were also present (results not shown). The vertebrate
Hes genes, homologues of Drosophila Hairy and Enhancer
of split, are targets of Notch and function as proneural
repressors in the CNS (de la Pompa et al., 1997, see Bertrand
et al., 2002), but nothing is known about the expression of
these genes during early otic neurogenesis. Hes5 was
expressed concomitantly withDelta1 and Ngn1 in a scattered
fashion (Fig. 3Ad). Lfng was also expressed in a restricted
manner in the anterior domain but only after stage 12 (Fig.
2Ad). Lfng was initially expressed in the otic placode in a
broad unrestricted manner from stage 10 (not shown), but
then refined to the pattern shown in Fig. 2Ad. As illustrated
in Fig. 3A, all proneural genes studied were restricted to the
same anterior-medial domain as FGF10. We call this domain
the pro-Neural-Sensory domain (proNS), as it foreshadows
the neurogenic and sensory domains of the otic vesicle (see
Adam et al., 1998 and Cole et al., 2000). The sequence of the
onset of expression of the complete gene collection studied
was: FGF10 (stage 11) > Ngn1, Delta1, Hes5 (stage 11+, 14
somites) > NeuroD, NeuroM (stage 12).
Fig 3B shows in more detail the expression profile of
Delta1, NeuroD, and NeuroM during the transit between the
otic placode and the otic vesicle. Delta1 was expressed from
otic placode to otic vesicle following a similar pattern as the
one described above for FGF10 (Figs. 3Ba–c, upper row).
Delta1-expressing cells, as previously reported by Adam et
al. (1998), were always confined to the otic epithelium- and
not in the CVG. NeuroD was first detected at stage 12, also
in scattered cells (not shown), and at otic cup stage, NeuroD
was intensely expressed in the proNS (Fig. 3Bd). By stage
16, NeuroD-positive cells populated the CVG (Fig. 3Be),and by stages HH18–19, NeuroD expression diminished in
the otic epithelium (always ventral), but now positive
neuroblasts were found in most cells of the CVG (Fig.
3Bf). This indicates that NeuroD is expressed in epithelial
neuroblasts and as the CVG is formed by their translocation,
the number of NeuroD cells in the otic epithelium is slowly
reduced. NeuroM, another neuronal differentiation factor
closely related to NeuroD, was also found in the neural-
sensory domain of the otic epithelium at otic cup stages
(Fig. 3Bg), and followed a similar regional and temporal
pattern of expression. However, by stage 18–19 (Fig. 3Bi),
NeuroM expression was only detected in the distal-most
domain of the CVG and no NeuroMpositive cells were
seen within the epithelium. Since it is known that vestibular
neurons are placed more distal than cochlear neurons
(D’Amico-Martel, 1982; Hemond and Morest, 1991), it is
tempting to suggest that NeuroM may be critical for spec-
ification of vestibular vs. cochlear identity.
Following what is known about proneural genes in
vertebrates (Bertrand et al., 2002), Ngn1 and Delta1 expres-
sion in the otic epithelium probably reflect the step of
selection of progenitors and their commitment to neuronal
fate, whereas NeuroD/M reflects the acquisition of the state
of neuronal determination (see also Fig. 7 in Discussion).
Note that Delta1 (as Ngn1) is a transient state exhibited by
neuronal precursors, whereas as shown in Fig. 3, NeuroD is
much more stable (otic epithelium and ganglion) and
reflects the cumulative generation of epithelial neuroblasts.
In the following experiments, we shall use NeuroD as the
output of neuronal cell determination.
Overexpression of FGF10 induces an increase of
NeuroD-expressing cells
To examine the role of FGF10 in otic neurogenesis, we
studied the effects on gene expression of local delivery of
recombinant FGF10 protein with heparan microbeads.
FGF10-soaked beads were implanted in stages 11–12
embryos under the ectoderm and anterior to the otic placode
of one side, the other being the control (Figs. 4Aa and b).
Ectopic FGF10 increased the expression of NeuroD and
NeuroM within the proNS domain (Figs. 4Ac–f, upper and
middle rows; 12/17 experiments). Examination of sections
treated with FGF10 showed no ectopic or aberrant sites of
delamination in otic vesicles exposed to FGF10 beads, and
beads implanted posterior to otic placode did not show
ectopic expression of NeuroD or Delta1 (results not shown).
Delta1 expression did not change with FGF10 delivered
with microbeads (Figs. 4Ag and h; 9/9 experiments).
Further confirmation of the effects of FGF10 on NeuroD
was obtained with electroporation experiments. FGF10 was
subcloned in a pCAGGS bicistronic vector using GFP as a
reporter and electroporated into the otic placode/cup at
stages 10–12, allowing embryos to develop for 24 h (Fig.
4Ba). Expression of GFP was restricted to the otic vesicle
(Fig. 4Bb) and co-localized with the sites of FGF10 over-
Fig. 3. FGF10 is expressed in the proneural-sensory domain. (A) Dorsal views showing the expression of FGF10 (a), Neurogenin1 (Ngn1) (b), Delta1 (c), Hes5
(d), NeuroD (e), and NeuroM (f) in otic cups of stage 14 embryos. All proneural and neurogenic genes are expressed in an anterior region within the FGF10
expression domain. The profile of the otic cup was enhanced by dotted lines. Note the neuroblasts from the VII placode expressing NeuroD and NeuroM anterior
to the otic cup. In the otic cup, the proneural differentiation gene NeuroM (f) was expressed in fewer cells in comparison to NeuroD (e). The sequence of gene
activation is represented in the bottom line. Restricted expression of FGF10 was detected before the detection of the first Delta1 and Ngn1 expressing cells. (B)
Lateral views ofDelta1, NeuroD, andNeuroM expression profiles in early otic cup (stages 12–14), late otic cup (stage 16), and otic vesicle stage (stages 17–19).
Delta1 was always detected in scattered cells in the anterior epithelial wall of the otic cup. In later stages, its expression was also restricted to the anterior-ventral
domain. Delta1 was not found in the CVG in later stages suggesting that it is expressed only in neuronal precursor cells. NeuroD and NeuroM were detected in
the otic epithelium as well as in neuroblasts populating the CVG, indicating that these genes are expressed in neuronal-determined cells. At later stages, NeuroD
was detected in the otic epithelium and in the CVG, while NeuroM was only found in the distal neuroblasts of the CVG. CVG: cochleovestibular ganglion. A:
anterior, L: lateral, D: dorsal.
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an electroporated embryo that was assayed for NeuroD
expression by whole mount in situ hybridization (Figs.
4Bc and d). Overexpression of FGF10 caused an increase
in NeuroD-positive cells in the anterior domain of the otic
vesicle (proNS). Although FGF10 was intensely expressedall throughout the otic vesicle (Fig. 4Bb), it did not induce
the ectopic expression of NeuroD, indicating that this took
place only within a neural competent domain. Vibratome
sections in Figs. 4Be and f show the increase of NeuroD in
the electroporated side (Fig. 4Bf) as compared to the non-
electroporated (Fig. 4Be, parasagittal sections). Again, Del-
Fig. 4. Induction of NeuroD and NeuroM expression by local implantation of FGF10-coupled beads and electroporation of the FGF10 cDNA. (A) Recombinant
FGF10 was coupled to acrylic heparin beads and implanted under the ectoderm anterior to the otic placode/cup (stages 10–12). (Aa, b) Embryos were
incubated for 18–24 h and processed for NeuroD, NeuroM, or Delta1 expression as markers of the neuronal determination pathway. Ac, e, and g show otic
vesicles of the untreated sides and Ad, f, and h show otic vesicles with implanted FGF10 beads. Asterisks show bead position. As observed in top and middle
rows, exposure to increased levels of FGF10 in the anterior domain induced the expression of NeuroD and NeuroM. No change was detected when Delta1 was
assayed for expression and compared between untreated (Ag) and FGF10 exposed otic vesicles (Ah). (B) FGF10 was subcloned into a pCAGGS–IRES–GFP
vector, DNA microinjected into the otic placode/cup (stages 10–13), in ovo electroporated and left for 24 h (Ba, b). Embryos with GFP expression restricted to
the otic vesicle were screened and processed for NeuroD and Delta1 expression. A representative embryo with GFP expression in the otic vesicle is shown in
Bb. Bc and d show lateral views of electroporated (d) and non-electroporated sides of the same embryo that was assayed for NeuroD by whole-mount in situ
hybridization. Be and f show vibratome parasagittal sections of an electroporated embryo processed for NeuroD. NeuroD expression increased in the
electroporated side but there was no ectopic expression in the posterior domain. No morphological defects in otic development were observed after
electroporation. Coronal sections of experiments processed for Delta1 expression are shown in Bg and h. No change was observed between the electroporated
(g) and non-electroporated vesicles (h). CVG: cochleovestibular ganglion. OV: otic vesicle. OP: otic placode. ProNS: proneural-sensory domain. A: anterior, P:
posterior, D: dorsal, M: medial.
B. Alsina et al. / Developmental Biology 267 (2004) 119–134126ta1 expression did not appear to change after FGF10 over-
expression (Figs. 4Bg and h, coronal sections).
Inhibition of FGF10 reduces NeuroD expression in the otic
cup
To further analyze the effects of FGF10, we made use of
otic explants grown in culture, which allow a more precise
and quantitative control of concentrations of added factors
and inhibitors (Fig. 5). Explants containing the otic placode
were dissected at stages 11–12 and grown in culture for
16–18 h in the presence of 1% FCS either alone (control),
with 200 ng/ml FGF10 (FGF10), or in the presence of 5–50
AM of the FGFR inhibitor SU5402 (SU5402). Then, theywere assayed for gene expression by in situ hybridization
and BrdU incorporation. A diagram of the experiment and
an example of a batch of explants are shown in Fig. 5A.
SU5402 belongs to a class of FGF receptor inhibitors that
inhibit the tyrosine-kinase activity of the FGF receptor by
interacting with its catalytic domain (Mohammadi et al.,
1997). Half-inhibitory concentrations of SU5402 range from
2 to 30 AM (McCabe et al., 1999; Mohammadi et al., 1997).
Fig. 5B shows the results from otic explants treated with
FGF10 and 50 AM SU5402 on NeuroD (Figs. 5Ba–c) and
Delta1 (Figs. 5Bd–f). SU5402 produced a dramatic inhibi-
tion of both NeuroD and Delta1 expression when compared
either to FGF10-treated or control explants (Fig. 5Bb, n =
11/14 for NeuroD and Fig. 5Be, 5/5 for Delta1), whereas
Fig. 5. Inhibition of FGF signaling suppresses NeuroD and Delta1 expression but not Lmx1. (A) In order to address the effects of FGF10 in neuroblast
generation, otic explants were incubated in 1% FCS alone (control) or 200 ng/ml of recombinant FGF10 (FGF10) or 50 Am of SU5402 (SU5402), an FGF
receptor inhibitor. The drawing represents a stage-10 embryo in which the most anterior part of the head and posterior to the 1st somite was excised and
cultured for 16 h, fixed and processed for NeuroD and Delta1 expression. A representative experiment with NeuroD expression in control, FGF10, or
SU5402 explants is shown in the right panel. Note small increment on NeuroD expression in the otic cups after FGF10 treatment, while its complete
suppression after incubation with the inhibitor. (B) Effects on NeuroD, Delta1, Ngn1, and Hes5 expression, and BrdU incorporation after FGF10 or SU5402.
Suppression of FGF-signaling abolished the expression of NeuroD (a–c) and Delta1 (d– f), Ngn1 (g– i), and Hes5 (j– l). FGF10 was able to induce NeuroD
(c) but not Delta1 (h). No major effects on cell proliferation were detected in SU5402-treated explants, showing that loss of expression was not due to
general growth retardation or toxic effects. (C) Lmx1 expression was not reduced by SU5402, indicating that the inhibitor suppression of proneural genes
was specific.
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explore more directly at which step of neurogenesis FGF
signaling is required, we performed similar experiments but
analyzing the expression of the determination gene Neuro-
genin1, which is upstream of Delta1 and Hes5, a target of
the Delta-Notch pathway (Figs. 5Bg–i and j–l). Blockade
of FGF receptors inhibited Ngn1 expression (Figs. 5Bg–i,
3/3) suggesting that it is required at very initial steps of
neuronal specification. Hes5 was also inhibited in these
experiments (Figs. 5Bj–l, 6/6), confirming that Delta1 was
functionally missing.SU5402 did not inhibit the expression of Lmx1 (Figs.
5Ca and b) or cell proliferation in the explants (Figs. 5Bm–
o), indicating that the loss of proneural genes was specific
and not caused by a general retardation of growth.
FGF10 does not induce proliferation of epithelial
neuroblasts but accelerates their transition to the state of
neuronal determination
Knowing that neuronal precursors are able to proliferate
in the CVG (Adam et al., 1998, Begbie et al., 2002;
B. Alsina et al. / Developmental Biology 267 (2004) 119–134128D’Amico-Martel, 1982) and that FGFs promote cell prolif-
eration in many systems, one possible explanation for the
increase of NeuroD caused by FGF10 and its reduction byFig. 6. FGF10 reduces proliferation in the proneural-sensory (proNS) region of th
CVG removed. Explants were incubated for 16–18 h with FCS, FGF10, or SU54
processed for NeuroD expression. Note the expression of NeuroD in neuroblasts i
FGF10-treated otic vesicles (Bb) in comparison to control vesicles (Ba). Again, SU
c) Detail of epithelial proneural-sensory domain (proNS) of three otic vesicles to
FGF10- (b), or SU5402-treated vesicles (c). Cd– f overlay confocal sections s
Confocal sections of otic vesicles in control (d), FGF10 (e), or SU5402 (f) condi
with NeuroD-expressing cells in the proNS region. After FGF10 treatment, reduc
this region. SU5402, in contrast, enhanced or maintained BrdU incorporation in th
performed on control (g), FGF10 (h), and SU5402 (i). (D) Expression of NeuroD p
were determined and NeuroD expression became independent from FGF signaling
treated CVG (b), indicating that ganglion expansion of neuroblasts was a
cochleovestibular ganglion.SU5402 is that FGF10 is required for proliferation of
NeuroD-expressing neuroblasts within the otic epithelium.
To test this possibility, we studied the effects of exposure toe otic vesicle. (A) Otic vesicles were isolated from stage-17 embryos and
02. The photomicrograph shows an otic vesicle that was incubated and then
n the otic epithelium (proNS), and in the CVG. (B) Induction of NeuroD in
5402 was able to reduce NeuroD expression in the otic vesicle (Bc). (Ca–
illustrate the changes in density of NeuroD-expressing cells in control (a),
howing NeuroD-expressing cells (black) and BrdU-labeled cells (green).
tions are shown. In control vesicles, BrdU-positive cells were intermingled
tion of BrdU occurred in the proNS region, with no apparent effect outside
e NeuroD-positive proNS domain. Cg– I show the results of TUNEL assay
ersisted in the CVG after treatment with SU5402, indicating that these cells
. High levels of BrdU-labeled cells were detected in the CVG of SU5402-
lso independent on FGF signaling. proNS: proneural-sensory, CVG:
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NeuroD and cell proliferation. To better understand the
effects, we wanted to have access to a broad window of
states of commitment of the neuroblast population, both in
the epithelium and the CVG. With this in mind, we
performed experiments with otic vesicles of stages 17–18
that show the coexistence of newly generated epithelial
neuroblasts (first expressing NeuroD), those that delaminate,
and also those ganglionar neuroblasts that populate the CVG
(which continue to express NeuroD as well as other
markers, see Alsina et al., 2003). Otic vesicles were grown
in culture for 16–18 h until they developed to equivalent
stages 20–22 (see diagram in Fig. 6A). Note that the
primordium of CVG was removed before culture (Fig.
6A) and that the epithelial (proNS) and ganglionar (CVG)
domains of NeuroD expression were well distinguished after
16–18 h in culture. Fig. 6B shows that the increase of
NeuroD induced by FGF10 (compare Fig. 6Ba and b, n =
16/19) and its suppression by SU5402 (Fig. 6Bc) recapitu-
lated the experiments described above (n = 17/18).
The density of cells expressing NeuroD in the proNS
territory was measured in representative control, FGF10-, or
SU5402-treated otic vesicles as described in methods from
preparations like those shown in Figs. 6Ca–c. NeuroD-
expressing cell density (number of cells per unit of proNS
surface area) was 529 F 89 in controls, 892 F 82 in the
presence of FGF10, and 356 F 21,2 with SU5402. The
relation of NeuroD/proNS surface area to the total area of
otic vesicles was measured in the same preparations using
the approach of McCabe et al. (1999) in the retina. In
control otic vesicles, the fraction of the NeuroD/proNS
surface area was 15.3 F 6% of the vesicle surface area
(n = 10). In FGF10-treated vesicles, this fraction was 22.6
F 8.1% (n = 14), and it was reduced to 8.5F 3. 2% (n = 14)
by SU5402. The net result of these experiments is that the
number of NeuroD-expressing cells increased with FGF10
and decreased with SU5402. The expansion of the measured
NeuroD-expressing surface area observed with FGF10 prob-
ably reflects the massive determination of normotopic pro-
genitors, rather than the ectopic expansion of the neurogenic
domain. Conversely, the SU5402-induced reduction of the
NeuroD domain reflects that cells were unable to transit to
NeuroD rather than the contraction of the neurogenic domain
(see also TUNEL experiments). The relationship between
FGF10, NeuroD expression, and cell proliferation was stud-
ied by double-labeling for BrdU incorporation (green) and
NeuroD expression (black). Figs. 6Cd–f displays overlay
confocal sections of otic vesicles from control (d), FGF10
(e), and SU5402 (f) treated otic vesicles, dotted lines
indicating the otic epithelium positive to NeuroD. In control
(Fig. 6Cd, control), BrdU-positive cells were intermingled
with NeuroD-expressing cells. However, treatment with
FGF10 reduced BrdU-positive cells within the NeuroD-
expressing domain, cell proliferation remaining high in the
adjacent region (Fig. 6Ce). On the other hand, SU5402
showed opposing effects on cell proliferation and NeuroDexpression (compare Fig. 6Ce, FGF10, and 6Cf, SU5402).
SU5402-treated otic vesicles showed low NeuroD expres-
sion and many BrdU-positive cells within the NeuroD
domain, whereas FGF10-treated vesicles exhibited the op-
posite. The density of proliferating cells in the proNS
territory was 12.5 F 3.1 cells per unit area in controls and
values were very similar in SU5402-treated vesicles (12 F
2.7 cells per unit area). In contrast, FGF10-treated vesicles
showed a reduction of BrdU cells down to 5.5F 1.9 cells per
unit surface (n = 4). This suggests that FGF10 may regulate
the transition to NeuroD fate by withdrawing progenitors
from cell division cycle. To analyze the question of whether
the loss of NeuroD after SU5402 was caused by an increase
of cell death, we carried out experiments using the TUNEL
assay. Results of TUNEL labeling of otic vesicles treated
with FGF10 and SU5402 are shown in Figs. 6Cg–i. The
general pattern of cell death in control-explanted otic
vesicles was similar to previous studies (Frago et al.,
1998). SU5402 treatment (Fig. 6Ci) did not increase signi-
ficantly cell death in the proNS domain of explanted otic
vesicles. Values were 6.6 F 1.7 apoptotic cells per unit area
in control explants vs. 9.4 F 4.8 with SU5402 (n = 7, P >
0.05). This indicates that the reduction on NeuroD-express-
ing cells observed with SU5402 was not caused by the loss
of progenitor cells but to their inability to gain the expression
of NeuroD. Surprisingly, FGF10 increased TUNEL-labeled
cells in otic vesicles was 20 F 9.7 cells/unit area (n = 8, P <
0.01, see also Fig. 6Ch). It is possible that FGF10, by
prompting premature cell determination, induces the apopto-
tic program in some cells that incorrectly enter into differ-
entiation (see Oesterle et al., 2000 and Mogi and Togari,
2003).
Fig. 6D shows a detail of the CVG from one otic vesicle
that was treated with SU5402 and assayed for NeuroD and
BrdU incorporation. As shown, in spite of the drastic
inhibition of NeuroD in the epithelium of the otic vesicle,
neuroblasts of the CVG continued to express NeuroD (Fig.
6Da) and to proliferate (Fig. 6Db). This implies that once
cells express NeuroD, they are no further dependent on FGF
signaling to support its expression, to delaminate, and to
proliferate within the CVG. NeuroD-expressing neuroblasts
are fully committed.Discussion
The interplay between intrinsic and extrinsic mecha-
nisms is believed to be crucial for ensuring the correct
number and identity of neurons in particular regions of
the embryo (Alsina et al., 2003; Edlund and Jessell,
1999). The results show that FGF10 defines an early
domain in the otic placode that anticipates the neural-
sensory competent region, whose regional and temporal
gene expression pattern we studied in detail. They also
show that FGF signaling is required for the acquisition of
proneural gene expression and determination of otic
B. Alsina et al. / Developmental Biology 267 (2004) 119–134130neuroblasts. We shall discuss first briefly the topic of the
regional compartmentalization of the otic placode, and
then proceed into the question of neural commitment and
the role of FGF10.
Is there an early compartmentalization of the otic placode?
The FGF10/proneural expression domain evolves highly
dynamically throughout the formation of the otic vesicle, in
such a way that it resolves into a ventral medial band that
is equatorial to the otic vesicle (see diagram of Fig. 1). The
generation of this domain may be explained by the dy-
namics of growth of the otic vesicle that displace the initial
anterior-medial domain of FGF10 to more ventral positions
(Brigande et al., 2000 and Alsina et al., preliminary
results).
Establishment of compartments and boundaries is
thought to be important for patterning and cell diversifica-
tion (reviewed in Dahmann and Basler, 2000). The remark-
able regionalization of gene expression in the otic vesicle
has suggested that this principle may operate during otic
development to ensure the coupling between the complex
three-dimensional topology of the inner ear, and the posi-
tioning and diversity of cell types (Fekete and Wu, 2002).Fig. 7. Early otic neurogenesis. States of cell commitment and differentiation of th
expression domain of Ngn1 and Delta1 specifies the proneural-sensory domain, th
believed that both neurons and sensory cells derive from a common progenitor, an e
the neuronal lineage is the epithelial neuroblast, Nbe, that emerges after neurona
committed to the neuronal fate. They are positive to NeuroD/M, but not yet to
determination, epithelial neuroblasts delaminate and condense into the CVG. Ne
markers as well as NeuroD and NeuroM. This cell state can be called ganglionar
which are determined as neurons but proliferative. FGF signaling is required to
neuroblasts) characterized by the expression of NeuroD/M. Once this state is re
FGF10. Other growth factors as IGF-I (Camarero et al., 2003) and FGF2 (Hossa
giving rise to post-mitotic immature neurons (IN) and starting their differentiation i
of some gene and marker expression of otic neurons and the particular gene comThe complementary expression of FGF10 with other
markers, such as Lmx1 and HNK-1 that are also early
regionalized, suggests that there is a very early subdivision
of the otic placode into two domains: one anterior-medial,
which is neural-sensory competent, and another posterior-
lateral domain, which is not. Differences in cell adhesion
molecules exist in the otic placode, as reflected by expres-
sion of the HNK1 epitope (present in many adhesion
molecules), in the posterior domain of the otic pit. The
HNK-1 carbohydrate structure, a sulfated glucuronyl-lacto-
saminyl residue carried by many neural recognition mole-
cules, including NCAM, L1, ependymin, and integrins, is
involved in cell interactions during development. The recent
observations that the cell adhesion molecule BEN is re-
stricted to the pro-neural sensory domain at stage 11 (Good-
year et al., 2001), and that of an Eph-ephrin interface is
established where neuroblast delamination occurs (Raft et
al., ARO 730 2002), are probably part of this early region-
alization of the placode.
Our observations on the delamination of otic neuroblasts
indicate that it takes place only at a particular subdomain of
the proneural-sensory region, at the posterior edge of the
FGF10 expression domain. This is somehow surprising
because it is frequently assumed that delamination occurse neuronal lineage are summarized along with molecular markers. The early
at is, the epithelium that will generate otic neurons and sensory organs. It is
pithelial multipotent progenitor cell, MPe. A second identifiable cell state in
l cell fate determination. Epithelial neuroblasts are epithelial cells that are
Islet or Tuj1, and exhibit a low if any proliferative activity. After cell
ural cells populating the CVG express Islet1/2, Tuj1 and cell proliferation
neuroblast, Nbg, and it constitutes a transit-amplifying population of cells,
shift multipotent precursors toward a state of full commitment (epithelial
ached, cells delaminate and continue their development independently of
in et al., 1996; Zhou et al., 1996) are critical then for transit amplification,
nto mature otic neurons (ON). The bar diagram displays the temporal pattern
bination that defines each cell state.
B. Alsina et al. / Developmental Biology 267 (2004) 119–134 131from the medial domain. The boundary between neural and
non-neural competent regions, as well as the above-men-
tioned differences in cell adhesion properties, may dictate
the site of delamination of neural cells that are generated
within the whole neurogenic domain. How neuroblast
generation and delamination are coupled at a particular site
is not known.
The sequence otic neuron generation
The present experiments deepen further in the character-
ization of the gene expression pattern throughout the gener-
ation of otic neurons (Adam et al., 1998; Cole et al., 2000).
Summarizing our results and previous information, we
model the process of otic neurogenesis as shown in Fig. 7.
The first visible output of otic neurogenesis is the
delamination of cells that populate the CVG, but neuronal
cell fate specification starts in the otic placode, as indicated
by the expression of both Neurogenin1 and Delta1 (Adam et
al., 1998; Ma et al., 1998, and our present results). Ngn1 and
Delta1 correspond to the specification of neuronal precur-
sors from a multipotent progenitor cell (MPe, Fig. 7). It is
believed that both neurons and sensory cells derive from a
common progenitor (see Lang and Fekete, 2001 for a
discussion). NeuroD and NeuroM (and the recently identi-
fied Prox1 gene, Stone et al., 2003) are expressed in the
epithelium of the otic cup, in delaminating neuroblasts, and
in the CVG. A second identifiable state in the neuronal
lineage can be called epithelial neuroblast (Nbe, Fig. 7),
which are epithelial cells that are committed to the neuronal
fate; they are positive to NeuroD/M, but not yet to Islet or
Tuj1 (see below), and exhibit a low, if any, proliferative
activity. After determination, epithelial neuroblasts delami-
nate and condense into the CVG. Neuronal cells populating
the CVG express Islet1/2, Tuj1, and cell proliferation
markers (Adam et al., 1998, Camarero et al., 2003), as well
as NeuroD and NeuroM. This state can be called ganglionar
neuroblast (Nbg), a transit-amplifying population of cells
that are determined as neurons but still proliferative and
dependent on IGF-1 (Camarero at el., 2003). Following this
scheme, we pursue further to discuss the effects of increas-
ing or decreasing FGF signaling during otic development.
FGF10 accelerates the transit toward irreversible
commitment
Intrigued by the observation of a regionalized expression
of FGF10 in the neuro-sensory region of the inner ear, we
analyzed the role of FGF10 in early stages of otic neuro-
genesis. Briefly, the increase in FGF10 activity by different
means promoted the expression of neuronal differentiation
genes NeuroD/NeuroM, whereas blockade of FGF signaling
interfered with neuronal determination.
Our interpretation of these results is that FGF10 shifts
multipotent precursors toward a state of determination. Once
this state is reached, cells delaminate and continue theirdevelopment independently of FGF10. The fact that Delta1-
positive cells are little affected by exposure to FGF10, while
it is suppressed by SU5402 in early otic placodes could be
explained by the transient nature of Delta1 expression (Fig.
7). FGF signaling would be required for epithelial precur-
sors to express Ngn1 and Delta1 1 (step 1, diagram Fig. 7),
but it would also shift the population to the next differen-
tiation state (step 2), the NeuroD-expressing epithelial
neuroblast, which is the cumulative out-reading of neuronal
determination. This should give a steady-state unchanged
Ngn1/Dl1 expression. Alternatively, the first step may be
dependent on a FGF signal different from FGF10 (see
below), and only the second step would require FGF10, as
gain of function experiments may suggest. This role of FGF
signaling in the otic placode is rather novel, but analogous
to those recently proposed for FGF8/FGFR4 in muscle
(Marics et al., 2002), and FGF1 and FGF receptors in the
onset of retinal ganglion cell differentiation in the chick
(McCabe et al., 1999).
FGF10-induced increase of neuronal differentiation
genes NeuroD, NeuroM is not associated with proliferation
of epithelial neuroblasts, which nevertheless has the capac-
ity to proliferate once they migrate to the CVG. Neuronal
precursors expressing NeuroD do not normally divide
within the otic epithelium and FGF10 does not increase
their cell proliferation rate. On the contrary, FGF10 reduces
cell division rate of progenitors. This is most strikingly
demonstrated by the opposing effects of FGF10 and
SU5402 on cell proliferation and NeuroD expression in otic
explants. It is interesting to note that NeuroD-expressing
cells do divide once in the CVG, where the proliferative
activity of neuronal precursors has been extensively docu-
mented (Adam et al., 1998; Begbie et al., 2002; Camarero et
al., 2003). This implies that NeuroD-expressing cells within
the otic epithelium are neuroblasts, but which remain
arrested until they become ganglionar neuroblasts. What
maintains these cells in quiescence or at a low proliferation
rate until they reach the CVG ? We do not know, but one
interesting possibility would be that they are silenced under
the influence of FGF10, and it is not until they enter a new
environment that they undergo transit-amplification. In this
connection, it has been recently shown that IGF-1 and
IGFR1 are expressed in the otic vesicle and ganglion, and
that IGF-1 is an essential requirement for cell survival and
proliferation of ganglionar neuroblasts (Fig. 7, Camarero et
al., 2003).
We have used SU5402 to test whether FGF signaling
would interfere with the generation of otic neuroblasts. The
drastic reduction of NeuroD-expressing cells with SU5402
can be explained by the inhibition of FGF10, as the
phenotype is opposite to what is obtained by increasing
the levels of FGF10. However, we cannot exclude that the
effects of SU5402 are due to the inhibition of other FGFs.
FGF12 in chick is broadly expressed in the ectoderm
including the otic placode and cup (Karabagli et al.,
2002), however, its expression is unrestricted. FGF8 is
B. Alsina et al. / Developmental Biology 267 (2004) 119–134132present in the otic placode, then is down-regulated during
otic cup stages and finally is expressed within a subdomain
of the proneural-sensory region of the otic vesicle (Adam-
ska et al., 2001; Hidalgo-Sanchez et al., 2000). These
patterns and timing of gene expression are not consistent
with the effects of FGF signaling described in the present
report.
In the mouse, but not in the chick, FGF3 and FGF10 are
both expressed in the neural-sensory epithelium of the otic
vesicle and in the CVG. The mouse knock-out of FGF3
(Mansour et al., 1993), as that of FGFR2(IIIb) exhibits a
reduction of the vestibulo-acoustic ganglion at E10.5 (Pir-
vola et al., 2000 ). The knock-out of FGF10 shows impaired
otic innervation but apparently it does not display strong
effects on the generation of otic neurons (Pauley et al.,
2003). This seems to be in contradiction with our results that
show that FGF10 and SU5402 affect early specification and
determination of otic neuroblasts. Pauley et al., 2003 point
that defects in the cochlea and otic neurons in the FGF10
knock-out are absent in areas of high expression of FGFR1b
and FGF10, suggesting that other FGFs—probably FGF3—
and other receptors may compensate for the absence of
FGF10. As mentioned above, FGF3 is not expressed in the
chick otic placode and otic cup (Wilkinson et al., 1989 and
our own unpublished results) suggesting that the possible
redundancy of FGF10 and FGF3 in mouse cannot take place
in the chick. It has been extensively documented along the
last few years that the FGF signaling system shows many
degrees of freedom, with several structural variants, receptor
interactions, and species differences (reviewed in Ornitz and
Itoh, 2001; Powers et al., 2000). This is illustrated by the
studies on otic induction showing how different combina-
tions of FGFs interchange for analogous functions during
ear induction in different animal species (zebrafish Phillips
et al., 2001; mouse Alvarez et al., 2003; Wright and
Mansour, 2003; and chick Ladher et al., 2000 and Vendrell
et al., 2000). We have no information on FGF receptor
expression in the chick inner ear. Based on binding studies,
FGFR-2IIIb is thought to be the potential target of FGF10,
although it also binds to FGFR-1, and FGFR-2 is also
activated by FGF1, 3, and 7 (Powers et al., 2000). Wright
and Mansour (2003) suggest that FGF3 and FGF10 partially
act via the FGFR1 receptor, since the double knock-out for
these genes produced different phenotypes from those of the
FGFR2 (IIIb) knock-out mice studied by Pirvola et al.
(2000). This is consistent with the possibility that FGF10
could also be acting via FGFR1 receptors like in the
branching of submandibular gland development (Hoffman
et al., 2002).
In summary, our results indicate that FGF signaling,
probably FGF10, is a key element in the regulation of initial
stages of neuronal fate determination. The more general
emerging picture is that extracellular signaling factors
regulate particular stages of the generation of otic neurons
as an example of interplay between intrinsic and extrinsic
factors in the regulation of neurogenesis.Acknowledgments
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